Managing CMR

Targeting Traditional CVD Risk Factors in Patients With Abdominal Obesity



Page: Go to Previous Page 1 of 2 Go to Next Page

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-5.By Alberti KG, Eckel RH, Grundy SM et al.

Apolipoprotein B and cardiovascular disease risk: position statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices. Clin Chem 2009;55:407-19.By Contois JH, McConnell JP, Sethi AA et al.

2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations. Can J Cardiol 2009;25:567-79.By Genest J, McPherson R, Frohlich J et al.

Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation. J Am Coll Cardiol 2008;51:1512-24.By Brunzell JD, Davidson M, Furberg CD et al.

Canadian Cardiovascular Society position statement--recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease. Can J Cardiol 2006;22:913-27 By McPherson R, Frohlich J, Fodor G, Genest J, Canadian Cardiovascular Society

AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 2006;113:2363-72 By Smith SC, Allen J, Blair SN et al.

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735-52 By Grundy SM, Cleeman JI, Daniels SR et al.

Managing abnormal blood lipids: a collaborative approach. Circulation 2005;112:3184-209 By Fletcher B, Berra K, Ades P et al.

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004;110:227-39 By Grundy SM, Cleeman JI, Merz CN et al.

Dyslipidemia management in adults with diabetes. Diabetes Care 2004;27:S68-71 By Haffner SM; American Diabetes Association

ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins. Stroke 2002;33:2337-41 By Pasternak RC, Smith SC, Bairey-Merz CN et al.

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97 By Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults